Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure
Clinical Efficacy of Artificial Liver Support System Using Combination of Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease - Related Liver Failure
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Listed as NCT03589820, this NA trial focuses on Liver Failure and Wilson Disease and remains ongoing. Sponsored by Third Affiliated Hospital, Sun Yat-Sen University, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Aug 2018 — Sep 2020 [monthly]
Enrolling By Invitation NA
First recorded
Jun 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Third Affiliated Hospital, Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .